26th Annual International Lung Cancer Congress

Release Date: October 8, 2025

Expiration Date: October 8, 2026

Activity Overview

Oncology health care professionals who treat patients with lung cancer have an increasing array of diagnostic and therapeutic tools at their disposal. In this online, on-demand virtual symposium, renowned experts in lung cancer distill the latest data on targeted agents, immunotherapy, surgery, and radiation oncology for the management of lung cancer.

This educational activity is an archive of the live symposium held on July 25 and 26, 2025.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Examine the role of biomarkers and testing strategies in optimizing and personalizing treatment selection in patients with thoracic malignancies.
• Assess the implications of recent clinical trial evidence as well as ongoing trials concerning the management of patients with thoracic malignancies.
• Determine approaches to integrating monotherapy and combination immunotherapeutic approaches in the management of patients with thoracic malignancies.
• Create strategies to integrate targeted and cytotoxic strategies for the management of patients with thoracic malignancies.
• Outline approaches to address disparities in care for patients with thoracic malignancies.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.